Protara Therapeutics, Inc. Cash Equivalents, at Carrying Value
Protara Therapeutics, Inc. (TARA) had Cash Equivalents, at Carrying Value of $17.08 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-11
- 2026-06-30: Cash Equivalents, at Carrying Value $17.08M.
- 2026-03-31: Cash Equivalents, at Carrying Value $14.74M.
- 2025-12-31: Cash Equivalents, at Carrying Value $163.54M.
- 2025-09-30: Cash Equivalents, at Carrying Value $12.55M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $17.08M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $14.74M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $163.54M 10-K · filed 2026-03-10 |
| 2025-09-30 | $12.55M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $31.50M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $91.46M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $40.33M 10-K · filed 2026-03-10 |
| 2024-09-30 | $51.76M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $89.58M 10-Q · filed 2025-08-11 |
| 2024-03-31 | $52.23M 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |